A new agent for the treatment of noninfectious uveitis: rationale and design of three LUMINATE (Lux Uveitis Multicenter Investigation of a New Approach to Treatment) trials of steroid-sparing voclosporin

Uveitis is an inflammatory, putative Th1-mediated autoimmune disease that affects various parts of the eye and is a leading cause of visual loss. Currently available therapies are burdened with toxicities and/or lack definitive evidence of efficacy. Voclosporin, a rationally designed novel calcineur...

Descripción completa

Detalles Bibliográficos
Autores principales: Anglade, Eddy, Aspeslet, Launa J, Weiss, Sidney L
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699819/
https://www.ncbi.nlm.nih.gov/pubmed/19668418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699819/
https://www.ncbi.nlm.nih.gov/pubmed/19668418

Ejemplares similares